KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherapy in patients ineligible for surgical resection, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Manish A, Bennouna, Jaafar, Doi, Toshihiko, Shen, Lin, Kato, Ken, Adenis, Antoine, Mamon, Harvey J, Moehler, Markus, Fu, Xiaolong, Cho, Byoung Chul, Bordia, Sonal, Bhagia, Pooja, Shih, Chie-Schin, Desai, Anjali, Enzinger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927908/
https://www.ncbi.nlm.nih.gov/pubmed/33533655
http://dx.doi.org/10.2217/fon-2020-0969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927908/
https://www.ncbi.nlm.nih.gov/pubmed/33533655
http://dx.doi.org/10.2217/fon-2020-0969

Ejemplares similares